celecoxib accord 100mg tvrdá tobolka
accord healthcare polska sp. z o.o., varšava array - 2124 celekoxib - tvrdá tobolka - 100mg - celekoxib
celecoxib accord 200mg tvrdá tobolka
accord healthcare polska sp. z o.o., varšava array - 2124 celekoxib - tvrdá tobolka - 200mg - celekoxib
celecoxib zentiva 100mg tvrdá tobolka
zentiva, k.s., praha array - 2124 celekoxib - tvrdá tobolka - 100mg - celekoxib
celecoxib zentiva 200mg tvrdá tobolka
zentiva, k.s., praha array - 2124 celekoxib - tvrdá tobolka - 200mg - celekoxib
levetiracetam g.l. pharma 1000mg potahovaná tableta
g.l. pharma gmbh, lannach array - 11237 levetiracetam - potahovaná tableta - 1000mg - levetiracetam
levetiracetam g.l. pharma 500mg potahovaná tableta
g.l. pharma gmbh, lannach array - 11237 levetiracetam - potahovaná tableta - 500mg - levetiracetam
thyrogen
sanofi b.v. - thyrotropin alfa - onemocnění štítné žlázy - hormony předního laloku hypofýzy a analogy, hypofyzární a hypotalamické hormony a analogy - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.
cardio-spect 0,5mg kit pro radiofarmakum
medi-radiopharma kft., Érd array - 10321 tetrafluoroboritan tetramibimĚĎnÝ - kit pro radiofarmakum - 0,5mg - technecium-(99mtc) sestamibi
technescan sestamibi 1mg kit pro radiofarmakum
curium netherlands b.v., petten array - 10321 tetrafluoroboritan tetramibimĚĎnÝ - kit pro radiofarmakum - 1mg - technecium-(99mtc) sestamibi
tecfidera
biogen netherlands b.v. - dimethyl fumarát - roztroušená skleróza - imunosupresiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).